1. Academic Validation
  2. HMOX1 expression influence the role of macrophage in EGFR-TKI resistance of lung adenocarcinoma

HMOX1 expression influence the role of macrophage in EGFR-TKI resistance of lung adenocarcinoma

  • Int Immunopharmacol. 2026 Jan 1;168(Pt 1):115795. doi: 10.1016/j.intimp.2025.115795.
Hongkun Fang 1 Hao Wang 2 Xinyue Liu 2 Yi Deng 3 Lishu Zhao 2 Kandi Xu 2 Li Ye 2 Yujin Liu 2 Wencheng Zhao 2 Ying Zhou 4 Qiyuan Li 5 Yayi He 6
Affiliations

Affiliations

  • 1 Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, People's Republic of China; Shandong ProvincialKey Medical and Health Laboratory of BT and IT for Thoracic Oncology (The First Affiliated Hospital of Shandong Second Medical University), Weifang, Shandong 261041, People's Republic of China.
  • 2 Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, People's Republic of China; School of Medicine, Tongji University, No 1239 Siping Road, Shanghai 200433, People's Republic of China.
  • 3 Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
  • 4 National Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Xiamen, 361102, People's Republic of China. Electronic address: yingzhou@xmu.edu.cn.
  • 5 National Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Xiamen, 361102, People's Republic of China; Department of hematology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361102, People's Republic of China; Department of Pediatrics, The First Affiliated Hospital of Xiamen University, School of medicine, Xiamen 361102, People's Republic of China. Electronic address: qiyuan.li@xmu.edu.cn.
  • 6 Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, People's Republic of China; School of Medicine, Tongji University, No 1239 Siping Road, Shanghai 200433, People's Republic of China. Electronic address: yayi.he@tongji.edu.cn.
Abstract

Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) is the first-line therapy for lung adenocarcinoma (LUAD) patients having EGFR-sensitive mutations. Although it has significantly prolonged survival of patients, resistance to EGFR-TKI treatment can not be avoided. While many intrinsic factors related to resistance have been identified, little is known about the role of non-tumor cells, particularly macrophages in the tumor microenvironment (TME), in TKI resistance. In the current study, we performed scRNA-seq analysis on 7458 cells from 12 patients with EGFR-TKI sensitive or resistant tumors to investigate the differential tumor microenvironment in these tumors. We identified significant differences in the immune cell fractions that presented between EGFR-TKI sensitive and resistant tumors, with lymphocytes being the predominant immune cells in EGFR-TKI resistant tumors, while myeloid cells were more prominent in EGFR-TKI sensitive tumors. We identified HMOX1hi macrophages, exhibiting an anti-inflammatory M2 polarization, are more abundant in EGFR-TKI resistant tumors than in EGFR-TKI sensitive tumors. We further revealed extensive communication between macrophages and CAM-related tumor cells through SPP1 and FN1 signaling. The findings suggested that manipulating HMOX1 expression in macrophages might change their function and modulate sensitivity of patients to EGFR-TKI.

Keywords

Drug resistance; EGFR-TKI; Lung adenocarcinoma; Macrophage; Single cell sequencing.

Figures
Products
Inhibitors & Agonists
Other Products